SAN DIEGO, June 02, 2025 -- BioAtla, Inc. (Nasdaq: BCAB) (the “Company”), a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic (CAB) antibody therapeutics for the...
Jeff Collins will serve as a judge in the Commercializing Innovation competition at the Wake Forest Business School in Winston-Salem, NC
News | 04. 24. 2008
